Hongbo Medicine is a fast-developing new drug research and development service and raw material drug production enterprise. It is a one-stop comprehensive service provider for new drug research and development and commercial production, and is committed to drug discovery, pharmaceutical technology research and development and commercial production of API intermediates. As a high-tech enterprise, the company has obtained 23 patents at home and abroad, including 22 domestic patents and American patents 1.
Referring to the listing process and time of listed companies in the past, it can be listed within 7- 14 days after subscription. The subscription time of Hongbo Pharmaceutical is 65438+1October 65438+September, so the listing time may be 65438+1October 27th-165438+1October 3rd. After the new shares are won, investors only need to ensure that there are enough subscription funds in their accounts.